MILWAUKEE, Wis., May 17, 2022 (GLOBE NEWSWIRE) — For the ninth consecutive year, WHR Group, Inc. (WHR) was named a Top Workplace by the Milwaukee Journal Sentinel. Top Workplaces surveys employee engagement and satisfaction at companies throughout the US. Awards are given to companies in different regions including the Northeast, Southeast, Midwest, Southwest, Rocky Mountains and […]
Continue ReadingMILWAUKEE, Wis., May 17, 2022 (GLOBE NEWSWIRE) — Pelo nono ano consecutivo, o WHR Group, Inc. (WHR) foi nomeado Top Workplace (Principal Local de Trabalho) pelo Milwaukee Journal Sentinel. O Top Workplace pesquisa o envolvimento e a satisfação dos funcionários em empresas de todos os EUA. Os prêmios são concedidos a empresas em diferentes regiões, […]
Continue ReadingMILWAUKEE, Wisconsin, 17 mai 2022 (GLOBE NEWSWIRE) — Pour la neuvième année consécutive, WHR Group, Inc. (WHR) a été nommé meilleur lieu de travail par le Milwaukee Journal Sentinel. Cette reconnaissance est basée sur l’engagement et la satisfaction des employés dans les entreprises dans l’ensemble États-Unis. Des prix sont décernés aux entreprises de différentes régions, notamment […]
Continue ReadingRoseau, May 17, 2022 (GLOBE NEWSWIRE) — The government of Dominica commissioned three primary schools over the weekend. The Morne Jaune Primary School, Stevens Primary School, and Wills Strathmore Stevens Primary were reopened and now possess modern education technology, climate-resilient infrastructure, and an advanced learning environment. The reconstruction and rehabilitation of these schools are done […]
Continue ReadingYICHANG, Chine, 16 mai 2022 /PRNewswire/ — Angel Yeast (en.angelyeast.com, SH600298), un fabricant international de levure et d’extraits de levure coté en bourse, a annoncé lors de la Journée internationale des familles (15 mai) la poursuite de son engagement de longue date à soutenir et promouvoir un mode de vie sain pour les familles du […]
Continue ReadingWALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration […]
Continue Reading